Also listed on Kotobuki Pharmaceutical Co., Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Nov 29, 2041 · Medium confidence
20-year base term ends Nov 29, 2041
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 12,077,519), so the cap could be lower.
Nov 29, 2021
Nov 29, 2041
Jun 16, 2026
This patent's term runs 291 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 29, 2021, when application PCT/JP2021/043540, the earliest non-provisional in its chain, was filed (this one was filed May 26, 2023) | Nov 29, 2041 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +291 days, USPTO patent term adjustment record | Sep 16, 2042 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,077,519) | capped to Nov 29, 2041 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 29, 2041 | Medium confidence |
Partial family
| Application PCT/JP2021/043540 | PCT application no patent term | no patent term |
| US 12,655,122 | this patent Nov 2041 | Nov 2041 |
| US 12,077,519 | In force no later than Nov 2041 | no later than Nov 2041 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 23, 2023 Reel 64041, frame 61 | Watanabe, Hideyuki; Kamikubo, Takashi; Kamikawa, Akio; Washio, Takuya; Seki, Yohei; Okuyama, Keiichiro; Ikeda, Osamu; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko; Miyasaka, Kozo | Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Jun 23, 2023 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Astellas Pharma Inc. | Assignment of Assignor's Interest |
| Jun 23, 2023 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Kotobuki Pharmaceutical Co., Ltd. | Assignment of Assignor's Interest |
| Mar 24, 2026 Reel 75202, frame 93 | Watanabe, Hideyuki; Kamikubo, Takashi; Kamikawa, Akio; Washio, Takuya; Seki, Yohei; Okuyama, Keiichiro; Ikeda, Osamu; Tomiyama, Hiroshi; Iwai, Yoshinori; Nakamura, Akihiko; Miyasaka, Kozo | Astellas Pharma Inc.; Kotobuki Pharmaceutical Co., Ltd. | Corrective Assignment to Correct the the Address of Assignee Kotobuki Pharmaceutical Co., LTD Previously Recorded on Reel 64041 Frame 61. Assignor(S) Hereby Confirms the Assignment. |
| Mar 24, 2026 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Astellas Pharma Inc. | Corrective Assignment to Correct the the Address of Assignee Kotobuki Pharmaceutical Co., LTD Previously Recorded on Reel 64041 Frame 61. Assignor(S) Hereby Confirms the Assignment. |
| Mar 24, 2026 reel/frame not recorded | Ikeda, Osamu; Iwai, Yoshinori; Kamikawa, Akio; Kamikubo, Takashi; Miyasaka, Kozo; Nakamura, Akihiko; Okuyama, Keiichiro; Seki, Yohei; Tomiyama, Hiroshi; Washio, Takuya; Watanabe, Hideyuki | Kotobuki Pharmaceutical Co., Ltd. | Corrective Assignment to Correct the the Address of Assignee Kotobuki Pharmaceutical Co., LTD Previously Recorded on Reel 64041 Frame 61. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 12,077,519.